The gastrin-releasing peptide receptor (GRPR) is considered an attractive target for molecular imaging, as it is overexpressed in several high-incidence solid tumors, such as prostate, breast, lung and colon cancer [10]. Here, GRPR is linked to malignant colon neoplasm.